Octapharma AG (CH)

https://www.octapharma.com

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein product manufacturers in the world and has been committed to patient care and medical innovation since 1983. Its core business is the development and production of human proteins from human plasma and human cell lines. Octapharma’s revenue forecast for 2015 is EUR 1.5 billion. Octapharma has 48 subsidiaries and representative offices and employs approximately 6,000 people worldwide to support the treatment of patients in over 100 countries with products across the following therapeutic areas: Haematology (coagulation disorders) Immunotherapy (immune disorders) Critical Care Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico. *

	Start	1983-01-01 established
	Group	Octapharma (Group)
	Industry	BLOOD PRODUCTS
	Person	Marguerre, Wolfgang (Octapharma 201209 Chairman + Founder)

	Region	Lachen SZ
	Country	Switzerland
	Street	2 Seidenstr.
	City	8853 Lachen SZ
	Tel	+41-55-451-2121
		Address record changed: 2020-12-02

Basic data	Employees	G: 5,001 to 10,000 (2012-12-31)
	Currency	EUR
	Annual sales	1,500,000,000 (revenue, forecast (2015) 2015-12-31)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]